Stockand J D, Sansom S C
Department of Medicine, University of Texas Medical School at Houston 77030, USA.
Am J Physiol. 1996 Jun;270(6 Pt 1):C1773-9. doi: 10.1152/ajpcell.1996.270.6.C1773.
The patch-clamp method, in conjunction with measurements of cell contraction, was employed to investigate activation by guanosine 3',5'-cyclic monophosphate (cGMP) and guanylyl cyclase-stimulating vasodilators of large Ca(2+)-activated K+ channels (BKCa) in human glomerular mesangial cells (MC). In cell-attached patches, with physiological NaCl bathing solutions, BKCa was activated transiently by nitroprusside [NP; a nitric oxide (NO) donor], atrial natriuretic peptide (ANP), and dibutyryl cGMP (DBcGMP), reaching peak responses between 10 and 60 s and decreasing to near baseline activity within the next 120 s. In the presence of LY-83583, a specific inhibitor of guanylyl cyclase, BKCa was activated on cell by DBcGMP but not by NP or ANP. In all cases, the increase in channel activity coincided with a decrease in channel amplitude, indicating that the membrane potential was approaching equilibrium potential as BKCa was activated. If membrane potential was maintained depolarized with 140 mM KCl in the bathing solution, DBcGMP induced a sustained activation of BKCa. In the continued presence of DBcGMP, BKCa was further activated when 100 nM angiotensin II (ANG II) was added to the bathing solution. Experiments were performed to determine the role of BKCa in the regulation by vasorelaxants of mesangial contraction measured as percent maximal and defined by reduction in length induced by replacing 135 mM bath NaCl with KCl. Contraction by ANG II (100 nM = 60.5%) was attenuated by NP (100 microM), ANP (1.0 microM), and DBcGMP (10 microM) in the absence, but not the presence, of iberiotoxin, a specific inhibitor of BKCa. These results indicate that guanylyl cyclase-stimulating vasorelaxants counteract ANG II-induced contraction of MC, in part, by repolarizing the membrane through activation of BKCa channels.
采用膜片钳技术并结合细胞收缩测量,研究了3',5'-环磷酸鸟苷(cGMP)和鸟苷酸环化酶刺激型血管舒张剂对人肾小球系膜细胞(MC)中大电导钙激活钾通道(BKCa)的激活作用。在细胞贴附式膜片中,用生理NaCl浴液时,硝普钠[NP;一种一氧化氮(NO)供体]、心房利钠肽(ANP)和二丁酰cGMP(DBcGMP)可短暂激活BKCa,在10至60秒之间达到峰值反应,并在接下来的120秒内降至接近基线活性。在存在鸟苷酸环化酶特异性抑制剂LY-83583的情况下,DBcGMP可在细胞上激活BKCa,但NP或ANP不能。在所有情况下,通道活性的增加与通道幅度的减小同时发生,表明随着BKCa被激活,膜电位接近平衡电位。如果用140 mM KCl使浴液中的膜电位保持去极化,DBcGMP会诱导BKCa持续激活。在持续存在DBcGMP的情况下,当向浴液中加入100 nM血管紧张素II(ANG II)时,BKCa会进一步被激活。进行实验以确定BKCa在血管舒张剂调节系膜收缩中的作用,系膜收缩以最大百分比衡量,并通过用KCl替代135 mM浴液NaCl诱导的长度减少来定义。在不存在BKCa特异性抑制剂iberiotoxin的情况下,ANG II(100 nM = 60.5%)引起的收缩可被NP(100 microM)、ANP(1.0 microM)和DBcGMP(10 microM)减弱,但在存在iberiotoxin的情况下则不然。这些结果表明,鸟苷酸环化酶刺激型血管舒张剂部分通过激活BKCa通道使膜复极化来抵消ANG II诱导的MC收缩。